QR Code

Review of fibromyalgia treatment guidelines: part 2 – pharmacological treatment

Abstract Fibromyalgia is a complex condition characterized by widespread chronic pain, fatigue, and sleep disturbances, which significantly affect quality of life. Its pathophysiology involves central sensitization (CS) and changes in neurotransmitters. Management is challenging and requires a multi...

Description complète

Enregistré dans:
Auteurs principaux: Roberto Ezequiel Heymann, Marcelo Cruz Rezende, Eduardo dos Santos Paiva, Marcos Renato de Assis, Alessandra de Sousa Braz, Aline Ranzolin, Ana Paula Monteiro Gomides Reis, Andrea Pimentel Fonseca Golmia, Anna Beatriz Assad Maia, Denison Santos Silva, Fernando Augusto Chiuchetta, Gabriela Galassi, Izabela Guimarães, José Eduardo Martinez, José Roberto Provenza, Juliana Maria de Freitas Trindade Costa, Marcos Paulo Veloso Correia, Marco Antônio Gonçalves Pontes Filho, Marco Aurelio Goldenfum, Marcos Aurelio de Freitas Machado, Melissa Mariti Fraga, Nilton Salles Rosa Neto, Rafael Navarrete Fernandez, Member of the Pain Committee of the Brazilian Society of Rheumatology
Format: Artigo
Langue:Inglês
Publié: BMC 2026-01-01
Collection:Advances in Rheumatology
Sujets:
Fibromyalgia
Chronic pain
Central sensitization
Guidelines
Pharmacological treatment
Duloxetine
Accès en ligne:https://doi.org/10.1186/s42358-025-00483-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires